Naproxeno Aurovitas

Naproxen, the active ingredient in Naproxeno Aurovitas, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as an oral tablet for oral use. It reduces pain, inflammation and fever, and is commonly prescribed for conditions such as osteoarthritis, rheumatoid arthritis and dysmenorrhea in adult patients.

GNH USA supplies Naproxeno Aurovitas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory documentation to support import and clinical use. Our global network ensures reliable delivery to authorized healthcare providers.

Naproxen is an NSAID that alleviates pain and inflammation across several musculoskeletal and gynecologic conditions.

- Pain: Provides analgesic relief for mild to moderate pain. - Osteoarthritis: Improves joint function and reduces stiffness. - Rheumatoid arthritis: Decreases inflammatory activity and joint swelling. - Dysmenorrhea: Relieves menstrual cramping and associated discomfort. - Fever: Lowers elevated body temperature in acute febrile states.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia or abdominal discomfort. - Headache: mild to moderate intensity. - Dizziness: transient vertigo or light‑headedness. - Rash: mild skin irritation or erythema.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration. - Renal impairment: reduced kidney function or acute failure. - Cardiovascular events: increased risk of thrombotic complications. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before initiating therapy, consider patient‑specific risk factors and monitor appropriately.

- Assess gastrointestinal risk: evaluate history of ulcers or bleeding. - Monitor renal function: check serum creatinine and electrolytes in at‑risk patients. - Evaluate cardiovascular history: use caution in patients with heart disease. - Use lowest effective dose: limit duration to the shortest period needed. - Avoid in known hypersensitivity: discontinue if allergic reaction occurs. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Naproxen may alter the pharmacokinetics or pharmacodynamics of several co‑administered medicines.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): heightened hemorrhagic potential.

Moderate Interactions (Monitor Closely): - ACE inhibitors: possible reduction in antihypertensive effect. - Diuretics: risk of reduced renal perfusion. - Methotrexate: potential for increased toxicity.